Professor Philip Chowienczyk
Professor of Clinical Cardiovascular Pharmacology
Research interests
- Cardiovascular
Contact details
Biography
Philip Chowienczyk is a Professor of Clinical Cardiovascular Pharmacology in the School of Cardiovascular Medicine & Sciences.
The publication feed is not currently available.
Research
Centre for Ageing Resilience In a Changing Environment - CARICE
Welcome to the Centre for Ageing Resilience in a Changing Environment: CARICE
News
Lower blood pressure reduces cardiovascular disease for children with chronic kidney disease
The HOT-KID clinical trial looked at how lowering blood pressure in children with chronic kidney disease could prevent cardiac remodelling and associated...
Paper by King's researchers makes Readers' Choice List 2021
The article was selected as one of The Pharmacogenomics Journal’s 15 most cited or shared articles in 2021.
Researchers reveal that first-phase ejection fraction is associated with increased mortality in patients with COVID-19
Researchers reveal that first-phase ejection fraction is associated with increased mortality in patients with COVID-19
The publication feed is not currently available.
Research
Centre for Ageing Resilience In a Changing Environment - CARICE
Welcome to the Centre for Ageing Resilience in a Changing Environment: CARICE
News
Lower blood pressure reduces cardiovascular disease for children with chronic kidney disease
The HOT-KID clinical trial looked at how lowering blood pressure in children with chronic kidney disease could prevent cardiac remodelling and associated...
Paper by King's researchers makes Readers' Choice List 2021
The article was selected as one of The Pharmacogenomics Journal’s 15 most cited or shared articles in 2021.
Researchers reveal that first-phase ejection fraction is associated with increased mortality in patients with COVID-19
Researchers reveal that first-phase ejection fraction is associated with increased mortality in patients with COVID-19